Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance
Abstract Impaired glucose tolerance (IGT) increases cardiovascular risk and can enlarge myocardial infarction (MI) incidence and severity. There is lack of information about cardioprotective potential of glucose-lowering drugs in IGT. We aimed to evaluate the sustainability of myocardium to ischemia...
Guardado en:
Autores principales: | Anna Simanenkova, Sarkis Minasian, Tatiana Karonova, Timur Vlasov, Natalya Timkina, Oksana Shpilevaya, Aleksandra Khalzova, Anzhelika Shimshilashvili, Valeria Timofeeva, Daniil Samsonov, Yury Borshchev, Michael Galagudza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7916bad8a0fc4ce5bf35c4f5a2338ae7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
por: A. V. Simanenkova, et al.
Publicado: (2021) -
Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
por: Vladimir Ivanovich Kudinov, et al.
Publicado: (2011) -
Mechanisms of neuroprotective action of incretin mimetics
por: Timur Dmitrievich Vlasov, et al.
Publicado: (2016) -
Metformin in patients with ischemic heart disease and type 2 diabetes mellitus: mechanism of action and clinical efficiency
por: Ekaterina Nikodimovna Kravchuk, et al.
Publicado: (2013) -
Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili H, et al.
Publicado: (2021)